XOMA Announces Results From Phase 3 EYEGUARD(TM)-B Study
Go back to XOMA Announces Results From Phase 3 EYEGUARD(TM)-B Study| XOMA (NASDAQ: XOMA) | Delayed: 41.79 -0.01 (0.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $41.80 | 52 Week High | $7.33 | |||
| Open | $41.80 | 52 Week Low | $0.34 | |||
| Day High | $41.90 | P/E | N/A | |||
| Day Low | $41.67 | EPS | $-0.73 | |||
| Volume | 129,397 | |||||

